· The world’s first donepezil patch is approved for the incrementally modified drug
· Launching in 2022, its availability will be expanded to the global market
SEOUL, South Korea, Nov 17 (Bernama-BUSINESS WIRE) — Icure Pharmaceutical Inc. (KOSDAQ: 175250), a biopharmaceutical company in Korea, announced today that its donepezil patch, a treatment of Alzheimer’s-type dementia, received a drug product approval from the Ministry of Food and Drug Safety of Korea.